Narrative Medicine for Improving Well-Being in Patients With Gastrointestinal Cancers

University of Southern California

Status: Completed

Conditions: Malignant Digestive System Neoplasm

Treatments: Other: Interview; Other: Survey Administration; Procedure: Discussion

Study type: Interventional

Funder types: Other; NIH

Identifiers

NCT06374251

P30CA014089 (U.S. NIH Grant/Contract)

NCI-2023-08890 (Registry Identifier)

0S-23-2 (Other Identifier)

Details and patient eligibility

About

This clinical trial assesses whether narrative medicine methods may improve the sense of well-being among gastrointestinal (GI) (digestive system) cancer patients. Narrative medicine is a clinical approach where providers can use a patient's own narrative (perspective) of their illness to promote healing and resilience. By applying narrative medicine's main tool, close reading, to clinical practice, clinicians learn to listen and attend to patients more deeply. This allows for freer communication and the creation of a healthcare encounter that centers on the psychological and emotional well being of the patient in addition to their medical conditions. Narrative medicine can include close reading, creative or reflective writing, and discussion. These methods may help patients with GI cancer to reflect on their life stories, both inside and outside of their illness experience, and help them gather skills to optimize their well-being.

Full description

PRIMARY OBJECTIVES:

I. To assess the feasibility of implementing narrative medicine tools in serial workshops with patients with malignancy.

II. To determine if narrative medicine interventions improve markers and expressions of well-being.

DESCRIPTIVE OBJECTIVES:

I. To estimate changes in markers and expressions of well-being after 3 sessions of narrative medicine intervention.

II. To determine, through qualitative methods, if patients find benefit from the intervention regarding their well-being.

III. To decide whether to expand these kinds of interventions to a larger study with control group.

OUTLINE:

Patients participate in narrative medicine sessions over 60 minutes once every 2 weeks (Q2W) for 3 sessions.

After completion of study intervention, patients are followed up at 1 and 3 months.

Enrollment: 8 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients with diagnosis of gastrointestinal malignancy actively receiving infusional therapy for cancer.
• Age >= 18 years.
• English speaking with ability to participate in reading and writing questionnaires and implementation tools.
• Performance Status =< Eastern Cooperative Oncology Group (ECOG) 3.

Exclusion criteria

• Altered mental status or other cognitive impairment, organic or drug induced that would limit ability to participate in the evaluation.

Trial design

Primary purpose: Supportive Care

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

8 participants in 1 patient group

Supportive Care (narrative medicine sessions)

Experimental group

Description:

Patients participate in narrative medicine sessions over 60 minutes Q2W for 3 sessions.

Treatment:

Procedure: Discussion

Other: Survey Administration

Other: Interview